Hbox

Brownie Prasad, a serial entrepreneur with previous experience in the health tech space, identified a significant gap in chronic disease management for specialty clinics. He recognized that Medicare reimburses between $140-200 per patient per month for remote monitoring and chronic condition management, yet clinics lacked an end-to-end solution combining hardware, software, and clinical services. This reimbursement opportunity provided the financial incentive to build a sustainable model that would benefit all stakeholders.

Hbox was built as a complete platform and services company offering:

- **Hardware**: Customized Android tablets branded as HealthPods, bundled with medical devices (pulse oximeters, blood pressure monitors, weight scales, glucose monitors) depending on the chronic condition. Prasad leveraged relationships with Chinese contract manufacturers from his previous venture to achieve a landed cost of approximately $200 per unit at 3,000-unit volumes. - **Software**: A platform to manage patient monitoring, data collection, and care coordination. - **Clinical Services**: In-house care coaches and billing infrastructure to manage claims and Medicare reimbursement processing.

The first commercial launch occurred in April 2023 with three initial customers acquired through Prasad's existing network from his previous venture. These early customers were crucial—the company made sure they generated revenue through Medicare reimbursement, creating strong advocates for the platform.

Hbox's customer acquisition has been entirely referral-driven with zero paid marketing spend. The first three customers came from Prasad's network; after that, customer growth became self-reinforcing. Early customers referred other physicians to the platform because the value proposition was irresistible: Hbox handles the entire remote monitoring workflow, processes Medicare claims (worth $300-350K per month in total claims volume), and splits reimbursement with the clinic. The clinic pays Hbox $60-80 per active patient per month—a fraction of the $140-200 Medicare reimbursement.

By the time of this interview, Hbox had grown to 100 providers (physicians) across eight U.S. states with 1,800 devices deployed, all through referral.

What worked: - **Network-driven growth**: Focusing on delivering exceptional results for early customers created natural referral momentum. As Prasad explained, "All of the 100 providers that we have on our platform is through referrals from existing customers. So we don't have a single sales person or a team that is going after." - **Solving a real financial problem**: By handling Medicare claims processing and guaranteeing reimbursement acceptance ("Yes, all those $350,000 in claims monthly get accepted and reimbursed"), Hbox made the economics undeniable for clinics. - **Retention through outcome alignment**: Zero churn so far, partly because the business model is backed by Medicare reimbursement for ongoing chronic condition management, creating stability and predictability. - **Patient expansion**: The three initial customers that started with 20 patients in month one expanded to 200-300 patients each within a year, demonstrating strong product-market fit.

Challenges: - Working capital: As patient volume scales (currently adding 300 patients/month, projected to reach 1,000/month in 3-4 months), hardware costs balloon. Each device costs ~$200, creating significant upfront capital requirements. - Funding strategy uncertainty: Prasad is torn between raising equity at his current 30M valuation cap (versus a likely 10x multiple in today's market for $1.4M ARR companies) and taking on debt to fund hardware inventory.

Hbox has raised $750K in pre-seed (5M cap) and $800K in seed (30M cap), giving them ~$600K remaining cash (20 months of runway at current $30K/month burn). The company is growing at a 14x rate year-over-year: - Year ago: $10K/month ($100K ARR) - Today: $120K/month ($1.4M ARR) - End-of-year projection: $3M ARR

With 100 physicians on platform managing 1,800 active patients and processing $300-350K in Medicare claims monthly, Prasad is now deciding between raising a Series A at a higher equity cost or pursuing $1-1.5M in debt financing to fund hardware purchases. The underlying business is cash-positive from day one—the challenge is optimal capital structure to accelerate growth while maximizing founder returns.